Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 8—August 2009

Invasive Group B Streptococcal Disease in the Elderly, Minnesota, USA, 2003–2007

Neelay J. KothariComments to Author , Craig A. Morin, Anita Glennen, Delois Jackson, Jane Harper, Stephanie J. Schrag, and Ruth Lynfield
Author affiliations: Minnesota Department of Health, St. Paul, Minnesota, USA (N.J. Kothari, C.A. Morin, A. Glennen, J. Harper, R. Lynfield); University of Minnesota, Minneapolis, Minnesota, USA (N.J. Kothari); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D. Jackson, S.J. Schrag)

Main Article

Table 2

Susceptibility of invasive GBS disease to erythromycin and clindamycin, Minnesota, 2003–2007*

Susceptibility No. (%) case-patients
p value†
(N = 133) 2004
(N = 127) 2005
(N = 131) 2006
(N = 143) 2007
(N = 121)
Erythromycin susceptible 95 (71.4) 86 (67.7) 87 (66.4) 90 (62.9) 71 (58.7) 0.023
Clindamycin susceptible 114 (85.7) 105 (82.7) 108 (82.4) 116 (81.1) 92 (76.0) 0.057

*GBS, group B streptococcal.
†χ2 test for trend.

Main Article

Page created: September 29, 2010
Page updated: September 29, 2010
Page reviewed: September 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.